Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400082363Phase 2Not yet recruiting
Phase 2 trial of xiaozhongcuyu tang in anal fistula (2 arms), sponsored by Xi'an Hospital of Traditional Chinese Medicine. Primary endpoint: Serum growth factor concentration. Planned start Mar 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400082363.